Abiopharma

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001839882-26-027560 <b>Size:</b> 342 KB

Director Mayo Stephen 🟢 acquired 1.9K shares (1 derivative) of Merck & Co., Inc. (MRK) Transaction Date: May 29, 2026 | Filing ID: 000155

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0000950103-26-008363 <b>Size:</b> 382 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001193125-26-253834 <b>Size:</b> 548 KB

📋 ALEXANDRE CLERC (Officer) plans to sell 5K shares of FRONTIER GROUP HOLDINGS, INC. (at $5.93 each, total $30K) Filed: Jun 02, 2026 | ID: 000621

Director Alvarez-Demalde Francisco 🟢 acquired 843 shares of Globant S.A. (GLOB) Transaction Date: Jun 01, 2026 | Filing ID: 039737

New Form 3 - TechnipFMC plc <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001628280-26-039866 <b>Size:</b> 352 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001193125-26-253833 <b>Size:</b> 453 KB

New Form 425 - Titan Acquisition Corp. <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001829126-26-005936 <b>Size:</b> 26 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001918704-26-015399 <b>Size:</b> 753 KB